Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indomobil Sukses Internasional Tbk. (IMAS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Indomobil Sukses Internasional Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Indomobil Sukses Internasional Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Indomobil Sukses Internasional Tbk. trades at Rp840 (market cap 3.4T, 57.5K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 3.7× Indomobil Sukses Internasional Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (235.2K versus 57.5K). Which is the better fit depends on your goals.

IMASTSPC
Market Cap
3.4T12.58T
Volume
57.5K235.2K
Lot
5752.35K
Turnover
48.76M649.94M
Average Price
847.962,763.37
Value
48.76M649.94M
Indicative Equilibrium Price
8502,780
Indicative Equilibrium Volume
3009

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IMAS
View details
TSPC
View details

About Indomobil Sukses Internasional Tbk.

PT Indomobil Sukses International Tbk (the Company) was initially established as a result of the merger between PT Indomulti Inti Industri Tbk (IMII) and PT Indomobil Investment corporation (IIC). The Company’s articles of association has been amended from time to time, most recently on June 30, 1999 in connection with the Company’s plans to offer shares with pre-emptive right. The Ministry of Justice has approved the amendment on July 5, 1999.

Read more on IMAS

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC